Article
[Pharmacogenomics of vitamin K antagonists].
Revista medica de Chile - 1 Sept 2020
Guzmán Neftalí, Vega Mario, Reyes Franco, Guzmán-Oyarzo Dina, Andaur Marcela, Boguen Rodrigo, Letelier Pablo
Abstract excerpt
There is an important interindividual variability in dose requirement for coumarinic anticoagulants, which could be explained by genetic and non-genetic factors. Among hereditary factors, there are gene polymorphisms that code the therapeutic target and the main enzyme responsible for their metabolism. However, there are other candidate genes that could modulate dose requirements. The is a paucity of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
